Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children
Clinical trial NCT02377427 · COMPLETED
Trial details
- NCT number
- NCT02377427
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-25
- Primary completion
- 2016-12-07
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.